Status | Study |
Recruiting |
Study Name: Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells Condition: Chronic Graft-Versus-Host Disease Date: 2014-11-05 Interventions: Biological: Mesenchymal Stromal Cells Mesenchymal stem cell(MSC). Patients with newly diagnosed cGvHD: p |
Recruiting |
Study Name: A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) Condition: Chronic Graft Versus Host Disease Date: 2013-09-27 Interventions: Drug: Abatacept The study will follow a standard 3+3 design with two escalating doses of abatacept to de |
COMPLETED |
Study Name: Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) Condition: Chronic Graft Versus Host Disease Date: 2013-09-27 Interventions: The study will follow a standard 3+3 design with two escalating doses of abatacept to determine the maximum tolerated dose (MTD): 3 mg/kg (dose l |
Active, not recruiting |
Study Name: Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus Condition: Chronic Graft-versus-host Disease Date: 2013-05-01 Interventions: Drug: PredEver Firstline treatment with prednisone and Everolimus |
Terminated |
Study Name: Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease Condition: Chronic Graft-versus-host Disease Date: 2013-01-05 Interventions: Biological: Mesenchymal stem cells |
Recruiting |
Study Name: Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease Condition: Chronic Graft Versus Host Disease Date: 2012-09-04 Interventions: Drug: Ofatumumab Phase I: test an escalating dose of ofatu |
Recruiting |
Study Name: Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease Condition: Chronic Graft Versus Host Disease Date: 2012-02-01 Interventions: Biological: Biological: mesenchymal stem cell |
Completed |
Study Name: A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease Condition: Chronic Graft Versus Host Disease Date: 2011-06-22 Interventions: Drug: ECP(Methoxsalen)+Corticosteroids+Cyclosporine or Tacrolimus |
Active, not recruiting |
Study Name: Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease Condition: Chronic Graft-versus-host Disease Date: 2011-06-02 Interventions: Drug: Interleukin-2 Daily subcutaneous IL-2 (1 x 10^6 IU/m^2/day) for self-administration for 12 weeks f |
Terminated |
Study Name: Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD) Condition: Chronic Graft Versus Host Disease Date: 2010-12-01 Interventions: Other: PET-CT Scan PET-CT scan will be done at baseline (per standard of care), at onset and confirmatio |